Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 455 results.
User Information
Export Records
  1. 1.   Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection
  2. Tsou, Pei-Suen; Ali, Ramadan A; Lu, Chenyang; Sule, Gautam; Carmona-Rivera, Carmelo; Lucotti, Serena; Ikari, Yuzo; Wu, Qi; Campbell, Phillip; Gurrea-Rubio, Mikel; Maeda, Kohei; Fox, Sharon E; Brodie, William D; Mattichak, Megan N; Foster, Caroline; Tambralli, Ajay; Yalavarthi, Srilakshmi; Amin, M Asif; Kmetova, Katarina; Mazetto Fonseca, Bruna; Chong, Emily; Zuo, Yu; Maile, Michael; Imberti, Luisa; Caruso, Arnaldo; Caccuri, Francesca; Quaresima, Virginia; Sottini, Alessandra; Kuhns,Douglas; Fink,Danielle; Castagnoli, Riccardo; Delmonte, Ottavia; Kenney, Heather; Zhang, Yu; Magliocco, Mary; Su, Helen C; Notarangelo, Luigi D; Zemans, Rachel L; Mao-Draayer, Yang; Matei, Irina; Salvatore, Mirella; Lyden, David C; Kanthi, Yogendra; Kaplan, Mariana J; Knight, Jason S; Fox, David A
  3. JCI Insight. 2025, Apr 01;
  1. 2.   Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster
  2. Wachter, Brianna T; Xu, Qin; Shi, Lihong; Burbelo, Peter D; Myint-Hpu, Kathy; Schwartzberg, Pamela L; Rehman,Tauseef; Dewar,Robin; Boswell, Kristin L; Koup, Richard A; Oguz, Cihan; Imberti, Luisa; Bellusci, Lorenza; Pourhashemi, Sara; Khurana, Surender; Manthiram, Kalpana; Notarangelo, Luigi D; Delmonte, Ottavia M
  3. The journal of Allergy and Clinical Immunology. . 2025, Mar 03;
  1. 3.   Examining the bias-efficiency tradeoff from incorporation of nonconcurrent controls in platform trials: A simulation study example from the adaptive COVID-19 treatment trial
  2. Bonnett,Tyler; Potter, Gail E; Dodd, Lori E
  3. Clinical Trials (London, England). 2025, Feb 08; 17407745251313928.
  1. 4.   Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms
  2. Brandstetter Figueroa, Elisabeth; Frosch, Anne E P; Burrack, Kristina S; Dileepan, Gayathri; Goldsmith, Rachael; Harris, Morgan; Ikeogu, Nwando; Jibrell, Hodan; Thayalan, Sangeitha; Dewar,Robin; Shenoy, Chetan; Sereti, Irini; Baker, Jason V
  3. Open Forum Infectious Diseases. 2025, Feb; 12(2): ofaf048.
  1. 5.   TRa1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility
  2. Edmondson,Elijah; Kimura, Takahito; Hwang, Eunmi; Kim, Minjun; Warner,Andrew; Zhu, Yuelin; Zhao, Li; Yu, Yanlin; Zhu, Xuguang; Hernandez, Maria; Kedei, Noemi; Cheng, Sheue-Yann
  3. Scientific Reports. 2025, Jan 31; 15(1): 3892.
  1. 6.   Unraveling the dynamics of B7-H3-targeting therapeutic antibodies in cancer through PET imaging and antibody pharmacokinetics
  2. Fernandes, Bruna; Olkowski, Colleen P; Ghaemi, Behnaz; Basuli, Falguni; Shi, Jianfeng; Kiesewetter, Dale O; Lang, Lixin; Elijah, Edmondson; Swenson, Rolf; Choyke, Peter L; Lin, Frank I; Jacobson, Orit
  3. Journal of Controlled Release : official journal of the Controlled Release Society. 2025, Jan 13;
  1. 7.   Use of mobile phones to collect data on COVID-19: phone access and participation rates, in Rakai, Uganda
  2. Ssekubugu, Robert; Ndyanabo, Anthony; Makumbi, Fredrick; Ekström, Anna Mia; Beres, Laura; Nalwoga Kigozi, Grace; Nakawooya, Hadijja; Ssekasanvu, Joseph; Wawer, Maria J; Nalugoda, Fred; Sewankambo, Nelson; Ssempijja,Victor; Nantume, Betty; Serwadda, David; Kigozi, Godfrey; Gray, Ronald H; Chang, Larry W; Grabowski, M Kate; Nordenstedt, Helena; Kagaayi, Joseph
  3. Global Health Action. 2024, Dec 31; 17(1): 2419160.
  1. 8.   Insights into biofilm architecture and maturation enable improved clinical strategies for exopolysaccharide-targeting therapeutics
  2. Temme,Joel; Tan, Zibin; Li,Mi; Yang,Mo; Wlodawer,Alexander; Huang, Xuefei; Schneekloth,Jay; Gildersleeve,Jeffrey
  3. Cell Chemical Biology. 2024, Dec 02;
  1. 9.   Affinity Tag-Free Purification of SARS-CoV-2 N Protein and Its Crystal Structure in Complex with ssDNA
  2. Maiti,Atanu; Matsuo,Hiroshi
  3. Biomolecules. 2024, Nov 30; 14(12):
  1. 10.   Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem
  2. Ataca, Sila; Sangesland, Maya; de Paiva Fróes Rocha, Rebeca; Torrents de la Peña, Alba; Ronsard, Larance; Boyoglu-Barnum, Seyhan; Gillespie, Rebecca A; Tsybovsky,Yaroslav; Stephens,Tyler; Moin, Syed M; Lederhofer, Julia; Creanga, Adrian; Andrews, Sarah F; Barnes, Ralston M; Rohrer, Daniel; Lonberg, Nils; Graham, Barney S; Ward, Andrew B; Lingwood, Daniel; Kanekiyo, Masaru
  3. Cell Reports. 2024, Nov 22; 43(12): 114990.
  1. 11.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
  1. 12.   Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials
  2. Guerra-de-Blas, Paola Del Carmen; Marines-Price, Rubria; Milman, Olga; Deal,Danae; Marchand,Jon; Linton,Jessica; Meger, Sue; Rule, John; Holland, Thomas L; Kitonsa, Jonathan; Delph, Yvette
  3. Journal of Clinical and Translational Science. 2024, Oct 15; 8(1): e157.
  1. 13.   Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned
  2. Stransky, Laura A; Gao, Wenhua; Schmidt,Laura; Bi, Kevin; Ricketts, Christopher J; Ramesh, Vijyendra; James,Amy; Difilippantonio,Simone; Ileva,Lilia; Kalen,Joseph; Karim,Baktiar; Jeon, Albert; Morgan,Tamara; Warner,Andrew; Turan, Sevilay; Unite,Joanne; Tran,Bao; Choudhari,Sulbha; Zhao,Yongmei; Linn, Douglas E; Yun, Changhong; Dhandapani, Sripriya; Parab, Vaishali; Pinheiro, Elaine M; Morris,Nicole; He, Lixia; Vigeant, Sean M; Pignon, Jean-Christophe; Sticco-Ivins, Maura; Signoretti, Sabina; Van Allen, Eliezer M; Linehan, W Marston; Kaelin, William G
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Oct 08; 121(41): e2408549121.
  1. 14.   Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
  2. Fong, Youyi; Dang, Lauren; Zhang, Bo; Fintzi, Jonathan; Chen, Shiyu; Wang, Jing; Rouphael, Nadine G; Branche, Angela R; Diemert, David J; Falsey, Ann R; Losada, Cecilia; Baden, Lindsey R; Frey, Sharon E; Whitaker, Jennifer A; Little, Susan J; Kamidani, Satoshi; Walter, Emmanuel B; Novak, Richard M; Rupp, Richard; Jackson, Lisa A; Yu, Chenchen; Magaret, Craig A; Molitor, Cindy; Borate, Bhavesh; Babu, Tara M; Kottkamp, Angelica C; Luetkemeyer, Anne F; Immergluck, Lilly C; Presti, Rachel M; Bäcker, Martín; Winokur, Patricia L; Mahgoub, Siham M; Goepfert, Paul A; Fusco, Dahlene N; Atmar, Robert L; Posavad, Christine M; Mu, Jinjian; Makowski, Mat; Makhene, Mamodikoe K; Nayak, Seema U; Roberts, Paul C; Follmann, Dean; Gilbert, Peter B
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Sep 26;
  1. 15.   SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir
  2. Singh, Kanal; Rubenstein,Kevin; Callier,Viviane; Shaw-Saliba, Katy; Rupert,Adam; Dewar,Robin; Laverdure,Sylvain; Highbarger,Helene; Lallemand,Perrine; Huang, Meei-Li; Jerome, Keith R; Sampoleo, Reigran; Mills, Margaret G; Greninger, Alexander L; Juneja, Kavita; Porter, Danielle; Benson, Constance A; Dempsey, Walla; El Sahly, Hana M; Focht, Chris; Jilg, Nikolaus; Paules, Catharine I; Rapaka, Rekha R; Uyeki, Timothy M; Lane, H Clifford; Beigel, John; Dodd, Lori E
  3. The Journal of Infectious Diseases. 2024, Sep 23; 230(3): 624-634.
  1. 16.   Impact of baseline SARS-CoV-2 load in plasma and upper airways on the incidence of acute extrapulmonary complications of COVID-19: a multicentric, prospective, cohort study
  2. Jensen, Tomas O; Harper, Katrina; Gupta, Shaili; Liu, Sean T; Dharan, Nila J; Baker, Jason V; Pett, Sarah L; Shaw-Saliba, Kathryn; Esmail, Aliasgar; Ho, Minh Q; Almasri, Eyad; Dewar,Robin; Lundgren, Jens; Vock, David M
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2024, Sep 13;
  1. 17.   Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19
  2. Reilly, Cavan; Mylonakis, Eleftherios; Dewar,Robin; Young, Barnaby; Nordwall, Jacqueline; Bhagani, Sanjay; Chia, Po-Ying; Davis, Ruby; Files, Clark; Ginde, Adit A; Hatlen, Timothy; Helleberg, Marie; Hayanga, Awori; Jensen, Tomas O; Jain, Mamta K; Kalomenidis, Ioannis; Kim, Kami; Lallemand,Perrine; Lindegaard, Birgitte; Menon, Anupama; Ognenovska, Katherine; Poulakou, Garyfallia; Thorup Røge, Birgit; Rogers, Angela J; Shaw-Saliba, Katy; Sandkovsky, Uriel; Trautner, Barbara W; Vasudeva, Shikha S; Vekstein, Andrew; Viens, Kimberley; Wyncoll, James; DuChateau, Brian; Zhang, Zhenxing; Wu, Shujiang; Babiker, Abdel G; Davey, Victoria; Gelijns, Annetine; Higgs, Elizabeth; Kan, Virginia; Lundgren, Jens; Matthews, Gail V; Lane, H Cliff
  3. The Journal of Infectious Diseases. 2024, Sep 12;
  1. 18.   MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
  2. DeBarros, Kenya; Khan, Mahfuz; Coleman, Morgan; Bond, Vincent C; Floyd, Virginia; Gbodossou, Erick; Diop, Amad; Krumpe,Lauren; O'Keefe,Barry; Powell, Michael D
  3. Viruses. 2024, Sep 07; 16(9):
  1. 19.   Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019
  2. Jilg, Nikolaus; Giganti, Mark J; Chew, Kara W; Shaw-Saliba, Katy; Ritz, Justin; Moser, Carlee; Evering, Teresa H; Daar, Eric S; Eron, Joseph J; Currier, Judith S; Hughes, Michael D; Lane, H Cliff; Dewar,Robin; Smith, Davey M; Li, Jonathan Z
  3. Clinical Infectious diseases : an official publication of the Infectious Diseases Society of America. 2024, Jul 17;
  1. 20.   Longitudinal analysis of the lung proteome reveals persistent repair months after mild to moderate COVID-19
  2. Kanth, Shreya M; Huapaya, Julio A; Gairhe, Salina; Wang, Honghui; Tian, Xin; Demirkale, Cumhur Y; Hou, Chunyan; Ma, Junfeng; Kuhns,Doug; Fink,Dani; Malayeri, Ashkan; Turkbey, Evrim; Harmon, Stephanie A; Chen, Marcus Y; Regenold, David; Lynch, Nicolas F; Ramelli, Sabrina; Li, Willy; Krack, Janell; Kuruppu, Janaki; Lionakis, Michail S; Strich, Jeffrey R; Davey, Richard; Childs, Richard; Chertow, Daniel S; Kovacs, Joseph A; Parizi, Parizad Torabi-; Suffredini, Anthony F
  3. Cell Reports. Medicine. 2024, Jul 16; 5(7): 101642.
  1. 21.   TPPP-BRD9 Fusion-Related Gallbladder Carcinomas are Frequently Associated with Intracholecystic Neoplasia, Neuroendocrine Carcinoma, and a Distinctive Small Tubular-Type Adenocarcinoma Commonly Accompanied with a Syringomatous Pattern
  2. Pehlivanoglu, Burcin; Araya, Juan Carlos; Lawrence,Scott; Roa, Juan Carlos; Balci, Serdar; Andersen, Jesper B; Rashid, Asif; Hsing, Ann W; Zhu, Bin; Gao, Yu-Tang; Koshiol, Jill; Adsay, Volkan
  3. Human Pathology. 2024, Jul 05; 150: 67-73.
  1. 22.   Regulation of RAF family kinases: new insights from recent structural and biochemical studies
  2. Spencer-Smith, Russell; Morrison,Deborah
  3. Biochemical Society Transactions. 2024, June 26; 52(3): 1061-1069.
  1. 23.   "A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccination"
  2. Khalid, Muhammad B; Zektser, Ellen; Chu,Eric; Li, Min; Utoh, Joanna; Ryan, Patrick; Loving, Hanna S; Harb, Roa; Kattappuram, Robbie; Chatman, Lindsay; Hartono, Stella; Claudio-Etienne, Estefania; Sun, Guangping; Feener, Edward P; Li, Zhongbo; Lai, Samuel K; Le, Quang; Schwartz, Lawrence B; Lyons, Jonathan J; Komarow, Hirsh; Zhou, Zhao-Hua; Raza, Haniya; Pao, Maryland; Laky, Karen; Holland, Steven M; Brittain, Erica; Frischmeyer-Guerrerio, Pamela A
  3. The journal of Allergy and Clinical Immunology. . 2024, Jun; 153(6): 1634-1646.
  1. 24.   Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models
  2. Demirci, Selami; Khan,Muhammad; Hinojosa, Gabriela; Le, Anh; Leonard, Alexis; Essawi, Khaled; Gudmundsdottir, Bjorg; Liu, Xiong; Zeng, Jing; Inam, Zaina; Chu, Rebecca; Uchida, Naoya; Araki, Daisuke; London, Evan; Butt, Henna; Maitland, Stacy A; Bauer, Daniel E; Wolfe, Scot A; Larochelle, Andre; Tisdale, John F
  3. Cytotherapy. 2024, Jun ; 26(6): 641-648.
  1. 25.   Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
  2. Hartmann, Jordan A; Cardoso, Marcella R; Talarico, Maria Cecilia Ramiro; Kenney, Devin J; Leone, Madison R; Reese, Dagny C; Turcinovic, Jacquelyn; O'Connell, Aoife K; Gertje, Hans P; Marino, Caitlin; Ojeda, Pedro E; De Paula, Erich V; Orsi, Fernanda A; Velloso, Licio Augusto; Cafiero, Thomas R; Connor, John H; Ploss, Alexander; Hoelzemer, Angelique; Carrington,Mary; Barczak, Amy K; Crossland, Nicholas A; Douam, Florian; Boucau, Julie; Garcia-Beltran, Wilfredo F
  3. Cell. 2024, Apr 11;
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel